Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy: Neuromuscular Disorders

K.R. Wagner, H.Z. Abdel-Hamid, J.K. Mah, C. Campbell, M. Guglieri, F. Muntoni, Y. Takeshima, C.M. McDonald, A. Kostera-Pruszczyk, P. Karachunski, R.J. Butterfield, E. Mercuri, C. Fiorillo, E.S. Bertini, C. Tian, J. Statland, A.B. Sadosky, V.S. Purohit, S.P. Sherlock, J.P. PalmerM. Binks, L. Charnas, S. Marraffino, B.L. Wong

Research output: Contribution to journalArticlepeer-review

Cite this